Avaxia Biologics Secures $1,243,378 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38e20fa9-fb23-4094-a11f-d2456ef2af5a&Preview=1 -
Date
1/9/2012 -
Company Name
Avaxia Biologics -
Mailing Address
128 Spring Street Lexington, MA 02421 -
Company Description
Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract. -
Website
http://www.avaxiabiologics.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,243,378 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended. -
M&A Terms
-
Venture Investor
Undisclosed
